The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S,E)-2-{4-[2-Hydroxy-3-(1H-indol-1-yl)-propoxy]phenyl}-5-hydroxy-7-methoxy-2,3-dihydrochromen-4-one ID: ALA5267596
Max Phase: Preclinical
Molecular Formula: C27H25NO6
Molecular Weight: 459.50
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(O)c2c(c1)O[C@H](c1ccc(OCC(O)Cc3c[nH]c4ccccc34)cc1)CC2=O
Standard InChI: InChI=1S/C27H25NO6/c1-32-20-11-23(30)27-24(31)13-25(34-26(27)12-20)16-6-8-19(9-7-16)33-15-18(29)10-17-14-28-22-5-3-2-4-21(17)22/h2-9,11-12,14,18,25,28-30H,10,13,15H2,1H3/t18?,25-/m0/s1
Standard InChI Key: QBESQYQRVAZZBF-LYIYLXCWSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
-2.6079 -2.3510 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6079 -1.5260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8964 -1.1094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8982 -0.2885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6130 0.1237 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.3256 -0.2869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3256 -1.1120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0355 -1.5237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0355 -2.3487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.7518 -1.1157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7518 -0.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4663 0.1251 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.1807 -0.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0373 0.1248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1837 0.1239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4662 -0.2903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2455 0.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2439 0.9469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4707 1.3596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1835 0.9489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9584 1.3595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6729 0.9469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3874 1.3595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1019 0.9469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8164 1.3595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3874 2.1845 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9026 2.1795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7092 2.3510 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1216 1.6369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5697 1.0241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9256 1.4654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1807 0.6810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6330 0.0700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8259 0.2364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
2 3 1 0
3 4 1 0
4 5 1 0
6 5 1 0
7 6 2 0
7 2 1 0
8 7 1 0
8 9 1 0
10 8 2 0
11 10 1 0
11 12 1 0
12 13 1 0
14 11 2 0
6 14 1 0
4 15 1 6
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 15 2 0
18 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
23 26 1 0
27 25 2 0
27 28 1 0
28 29 1 0
29 30 2 0
30 25 1 0
29 31 1 0
32 31 2 0
33 32 1 0
34 33 2 0
30 34 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 459.50Molecular Weight (Monoisotopic): 459.1682AlogP: 4.57#Rotatable Bonds: 7Polar Surface Area: 101.01Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.69CX Basic pKa: ┄CX LogP: 4.61CX LogD: 4.59Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.37Np Likeness Score: 0.75
References 1. Ferreira RJ, Gajdács M, Kincses A, Spengler G, Dos Santos DJVA, Ferreira MU.. (2020) Nitrogen-containing naringenin derivatives for reversing multidrug resistance in cancer., 28 (23.0): [PMID:33038666 ] [10.1016/j.bmc.2020.115798 ]